Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ICU | Common Stock, par value $0.0001 per share | Award | $0 | +60.2K | +7.75% | $0.00 | 838K | Nov 29, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ICU | Stock Option (Right to Buy) | 99.7K | Nov 29, 2023 | Common Stock | 99.7K | $1.84 | Direct | F2 | |||||
holding | ICU | Stock Option (Right to Buy) | 18K | Nov 29, 2023 | Common Stock | 18K | $10.00 | Direct | F3 | |||||
holding | ICU | Stock Option (Right to Buy) | 84K | Nov 29, 2023 | Common Stock | 84K | $0.53 | Direct | F4 |
Id | Content |
---|---|
F1 | The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. |
F2 | All options reported herein will vest, subject to continued service, on April 6, 2024, the first anniversary of the date of grant. |
F3 | These options are fully vested. |
F4 | The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021. |